Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

387.10
-4.0700-1.04%
Post-market: 387.100.00000.00%19:30 EDT
Volume:688.10K
Turnover:265.36M
Market Cap:19.18B
PE:36.80
High:391.02
Open:384.84
Low:379.94
Close:391.17
52wk High:625.99
52wk Low:233.78
Shares:49.56M
Float Shares:48.15M
Volume Ratio:0.95
T/O Rate:1.43%
Dividend:0.80
Dividend Rate:0.21%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:8.61
PE(LYR):36.80

Loading ...

Stock Track | Carpenter Technology Plummets 5.97% Intraday as Profit-Taking Erases Pre-Earnings Optimism

Stock Track
·
Apr 30

Specialty alloy maker Carpenter Technology Q3 sales rise 12%, beat estimates

Reuters
·
Apr 29

Carpenter Tech Q3 Adj. EPS $2.77 Beats $2.63 Estimate, Sales $811.500M Beat $798.260M Estimate

Benzinga Earnings
·
Apr 29

BRIEF-Carpenter Technology Q3 Adjusted EPS USD 2.77 Vs. IBES Estimate USD 2.63

Reuters
·
Apr 29

Carpenter Technology Q3 Sales USD 811.5 Million VS. Ibes Estimate USD 798.3 Million

THOMSON REUTERS
·
Apr 29

Carpenter Technology Corp - FY2026 Adj Free Cash Flow Outlook Raised to Approx $350 Mln

THOMSON REUTERS
·
Apr 29

Carpenter Technology Q3 EPS USD 2.77

THOMSON REUTERS
·
Apr 29

Carpenter Technology Corp - FY2026 Operating Income Guidance Raised to $700 Mln-$705 Mln

THOMSON REUTERS
·
Apr 29

Carpenter Technology Corp - Q4 FY2026 Operating Income Guidance $205 Mln to $210 Mln

THOMSON REUTERS
·
Apr 29

Carpenter Technology Reports Third Quarter Fiscal Year 2026 Results

GlobeNewswire
·
Apr 29

CRS Initiative Launches, Tax Authorities to Verify Overseas Income for Three Consecutive Years

Deep News
·
Apr 23

Earning Preview: Carpenter Technology Q3 revenue expected to increase by 9.37%, and institutional views are bullish

Earnings Agent
·
Apr 23

Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia

GlobeNewswire
·
Apr 21

Carpenter Technology price target raised to $465 from $394 at JPMorgan

TIPRANKS
·
Apr 20

U.S. RESEARCH ROUNDUP-Carpenter Technology, IBM, Ulta Beauty

Reuters
·
Apr 20

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

GlobeNewswire
·
Apr 20

How Dividend Reaffirmation And Institutional Demand At Carpenter Technology (CRS) Has Changed Its Investment Story

Simply Wall St.
·
Apr 19

Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs

prnewswire
·
Apr 18

Carpenter Technology Announces Leadership Transition and Board Expansion

TIPRANKS
·
Apr 18

Carpenter names Brian Malloy CEO, Tony Thene to become executive chairman

Reuters
·
Apr 18